鹭燕医药：关于公司控股股东部分股份解除质押的公告

Core Viewpoint - Luyuan Pharmaceutical announced the release of stock pledges by its controlling shareholder, Xiamen Mediken Technology Co., Ltd, indicating a potential shift in the company's financial strategy and liquidity management [2] Group 1: Stock Pledge Release - The number of shares released from pledge is 22,523,834 shares [2] - This represents 16.32% of the shares held by the controlling shareholder [2] - The released shares account for 5.80% of the company's total share capital [2]